Co-Founder, CEO, Managing Partner at Back Bay Life Science Advisors, and a founding member of the DNB // Back Bay Partnership for Healthcare.
My decades long perspective is that the fundamental need for healthcare technology and delivery and the unrelenting progress that science and clinical development bring render healthcare companies a cornerstone of sound investment. Interesting to note in the DNB//Back Bay weekly review below that despite the profound volatility we've seen this week, fundamental metrics in the healthcare/life science sectors remain indicative of the long term expectations for upside. https://lnkd.in/eUk2bd3q